Literature DB >> 10525480

Cytokines and their role in the pathophysiology of osteoarthritis.

J Martel-Pelletier1, N Alaaeddine, J P Pelletier.   

Abstract

The specific causative agent of the pathological process of osteoarthritis (OA) has not yet been identified, however, episodic inflammation at the clinical stage is now a well documented phenomenon and believed to be involved in the disease progression. Interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) are the predominant proinflammatory cytokines synthesized during the OA process. Other cytokines having proinflammatory properties or catabolic factors could also contribute to this pathological condition, and those having antiinflammatory properties may be able to counteract the negative effects of the former on the disease process. In this chapter, we will review cytokine interactions and their modulatory effects on joint articular tissue metabolism, including their stimulatory and/or inhibitory actions, and their potential relevance to OA. We will also briefly survey the major biological factors, in relation to cytokines, that look promising for future therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525480     DOI: 10.2741/martel

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  67 in total

Review 1.  The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis.

Authors:  Jérémie Sellam; Francis Berenbaum
Journal:  Nat Rev Rheumatol       Date:  2010-10-05       Impact factor: 20.543

2.  Clinical evaluation of a powder of quality elk velvet antler for the treatment of osteoarthrosis in dogs.

Authors:  Maxim Moreau; Jacques Dupuis; Norbert H Bonneau; Manon Lécuyer
Journal:  Can Vet J       Date:  2004-02       Impact factor: 1.008

3.  Elevated expression of β1,4-galactosyltransferase-I in cartilage and synovial tissue of patients with osteoarthritis.

Authors:  Wei Liu; Zhiming Cui; Youhua Wang; Xinhui Zhu; Jianbo Fan; Guofeng Bao; Junjun Qiu; Dawei Xu
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

4.  Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade.

Authors:  M Grunke; H Schulze-Koops
Journal:  Ann Rheum Dis       Date:  2006-04       Impact factor: 19.103

5.  Molecular analysis of age and sex-related gene expression in meniscal tears with and without a concomitant anterior cruciate ligament tear.

Authors:  Robert H Brophy; Muhammad Farooq Rai; Zhiqi Zhang; Adelina Torgomyan; Linda J Sandell
Journal:  J Bone Joint Surg Am       Date:  2012-03-07       Impact factor: 5.284

6.  In vivo reduction or blockade of interleukin-1β in primary osteoarthritis influences expression of mediators implicated in pathogenesis.

Authors:  K S Santangelo; G J Nuovo; A L Bertone
Journal:  Osteoarthritis Cartilage       Date:  2012-08-27       Impact factor: 6.576

7.  Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta.

Authors:  L J Sandell; X Xing; C Franz; S Davies; L-W Chang; D Patra
Journal:  Osteoarthritis Cartilage       Date:  2008-06-18       Impact factor: 6.576

8.  Identification of SOX9 interaction sites in the genome of chondrocytes.

Authors:  Chun-do Oh; Sankar N Maity; Jing-Fang Lu; Jiexin Zhang; Shoudan Liang; Francoise Coustry; Benoit de Crombrugghe; Hideyo Yasuda
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

9.  Intracapsular pressure and interleukin-1beta cytokine in hips with acetabular dysplasia.

Authors:  Jun Xie; Masatoshi Naito; Akira Maeyama
Journal:  Acta Orthop       Date:  2010-04       Impact factor: 3.717

10.  F-spondin, a neuroregulatory protein, is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-beta activation.

Authors:  Mukundan G Attur; Glyn D Palmer; Hayf E Al-Mussawir; Mandar Dave; Cristina C Teixeira; Daniel B Rifkin; C Thomas G Appleton; Frank Beier; Steven B Abramson
Journal:  FASEB J       Date:  2008-09-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.